NASDAQ:NVDQ (NVDQ) (NVDQ) Stock Price, News & Analysis → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free NVDQ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$5.56▼$6.1550-Day Range N/A52-Week Range$5.84▼$12.74Volume5.96 million shsAverage Volume797,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisDividendOptions ChainSocial MediaStock AnalysisDividendOptions ChainSocial Media Get (NVDQ) alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About (NVDQ) Stock (NASDAQ:NVDQ)NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.Read More Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. NVDQ Stock News HeadlinesApril 23, 2024 | msn.comLenovo IdeaPad Pro 5i launched in India3 Price, specs and all detailsApril 23, 2024 | msn.comAt 2 years old, he became the face of the Flint water crisis. He still has questionsApril 23, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.April 6, 2024 | oilprice.comNatural Gas ETFs Among The Worst Performing EquitiesMarch 11, 2024 | ca.finance.yahoo.comT-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ)January 4, 2024 | markets.businessinsider.comEXCLUSIVE: The Man Who Shorts Cathie Wood And Jim Cramer Filed For New Bitcoin ETFs — Why Leveraged ETFs Are Investment ToolNovember 26, 2023 | msn.comThese exotic shares DOUBLE the return of Nvidia stock!November 15, 2023 | seekingalpha.comO'Keefe Stevens Advisory - Nvidia: The End Of An Era?April 23, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.October 20, 2023 | finance.yahoo.comNew Tesla, Nvidia ETFs Offer 200% LeverageOctober 19, 2023 | stockhouse.comREX Shares Partners with Tuttle Capital Management to Launch T-REX Single-Stock ETFsJanuary 27, 2023 | msn.comHunt says he has never paid a tax penalty amid growing calls for Zahawi to goDecember 1, 2022 | msn.comNaval Academy confirms it denied all religious vax exemption requestsNovember 19, 2022 | msn.comIs soccer now America's fifth major sport? Plenty of evidence that it has definitely arrived in the USAOctober 26, 2022 | msn.comDolphins work out former Patriots Super Bowl hero CB Malcolm ButlerOctober 10, 2022 | msn.comThe Most Exciting New Cruise Ships Coming SoonSeptember 2, 2022 | msn.comInfighting in Bengal BJP? Bengal president Sukanta Majumdar is a PUPPET, says top party leaderSeptember 1, 2022 | msn.comManufacturing Assembly Network creates 50 jobs with new recruitment pushJanuary 26, 2022 | fool.comNovadaq Technologies Inc.(NVDQ)January 20, 2022 | lse.co.ukArrow Explor. Regulatory NewsSee More Headlines Receive NVDQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NVDQ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/03/2017Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:NVDQ CUSIPN/A CIK1173293 Webnovadaq.com Phone+1-905-6293822FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesWilliam A. MacKinnonChairman of the BoardRick Mangat Ph.D.President, Chief Executive OfficerBio & Compensation - Roger DeckChief Financial OfficerBio & Compensation - Lori SwalmVice President of MarketingBio & Compensation - Derrick GuoGeneral Counsel, Corporate SecretaryBio & Compensation - Anthony F. GriffithsLead Independent DirectorLisa N. ColleranDirectorKaren A. LicitraDirectorBio & Compensation - Patrice E. MerrinIndependent DirectorThomas G. WellnerIndependent DirectorMore Executives NVDQ Stock Analysis - Frequently Asked Questions How were (NVDQ)'s earnings last quarter? (NVDQ) (NASDAQ:NVDQ) posted its earnings results on Wednesday, May, 3rd. The medical research company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.21) by $0.03. The medical research company earned $21.08 million during the quarter, compared to analysts' expectations of $20.12 million. How often does (NVDQ) pay dividends? What is the dividend yield for (NVDQ)? (NVDQ) announced a dividend on Friday, December 22nd. Stockholders of record on Wednesday, December 27th will be paid a dividend of $1.80 per share on Thursday, December 28th. The ex-dividend date is Tuesday, December 26th. Read our dividend analysis for NVDQ. What other stocks do shareholders of (NVDQ) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (NVDQ) investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Athabasca Oil (ATH), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Accenture (ACN), Apollo Commercial Real Estate Finance (ARI), Gran Tierra Energy (GTE) and NN (NNBR). This page (NASDAQ:NVDQ) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NVDQ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
